Benchmark: FDA’s Final Rule on Nonprescription Drugs with ACNU

Take this benchmark to assess how much you would benefit from taking the course on Nonprescription Drug Product with an Additional Condition for Nonprescription Use (ACNU). In a few minutes, you’ll gauge whether you understand why the rule exists, how it changes development and labeling, and what it means for access, safety, and market strategy.

What you’ll get from this benchmark:
– A quick read on your readiness to navigate separate applications for ACNU products and simultaneous Rx/OTC strategies
– Insight into labeling and packaging trade-offs that affect compliance and consumer comprehension
– A sense of how ACNU design choices impact equity, usability, and real-world safety
– Clarity on postmarketing reporting expectations and how they shape your surveillance systems
– Perspective on operational decisions (build vs. buy tech, metrics to track, retailer implications) that can make or break launch success

If the questions feel challenging or raise uncertainties about intent, trade-offs, or operational details, the course will help you close those gaps so you can bring compliant, consumer-centered ACNU products to market with confidence.